bioRxiv · 10.1101/2023.04.11.536272
A bioorthogonal antibody-based chemically-induced-dimerization switch for therapeutic application
Abstract
We present the Indinavir Ligand Induced Transient Engagement switch (IDV LITE Switch), a fully synthetic Chemically Induced Dimerization (CID) system wherein two humanized antibody fragments are heterodimerized by the antiviral drug indinavir. The IDV LITE Switch represents the first CID system made from fully humanized protein components and dimerized by a clinically approved small molecule drug lacking a mammalian target, making it an ideal bioorthogonal molecular switch for application in small-molecule controlled therapeutics.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Martinko, A. J., Tran, H. L., Simonds, E. F., Cooke, A. L., Huang, Z., Raguveer, S., Agullet, J. P., Prasad, S., Going, C., Marshall, L., Park, T., Banerjee, S., Macdonald, R., Jian, M., Ng, K., Palakodaty, A., Kaur, M., Ponce, A., Tabrizi, M., Hill, Z. B.. 2023-04-11. A bioorthogonal antibody-based chemically-induced-dimerization switch for therapeutic application. https://doi.org/10.1101/2023.04.11.536272
Cite the original work for its findings. Save a collection to share your selection of sources.